Sentence examples for substantial information needs from inspiring English sources

While previous studies have identified substantial information needs among people with RA, research has focused primarily on issues related to treatment options and side effects [ 9, 10] and the accessibility of RA information [ 11].

The current findings identified substantial unmet information needs in relation to medication.

People with depression have substantial unmet information needs and require strategies to deal with the difficulties they face.

The study by Barney, Griffiths and Banfield also points at another major problem from the patients' perspective: the substantial unmet information needs of patients, which includes information about the nature and causes of depression, stigma, medication, treatment and coping with the daily problems of having depression.

The current study suggests that people with depression have substantial unmet information needs in relation to relation to recognising and understanding depression, services and treatment, medication, coping with depression and its consequences, dealing with disclosure and stigma of depression, and comorbid conditions.

Health promotion focuses on behavior change, for which patients need substantial information and support, much of it difficult to get from clinicians.

While there has been substantial inquiry into the patients information needs in the referral process and methods to address those in other countries, less has occurred in the US [ 21, 22].

She knows so many people that had it and then they die, so she is fearful and angry about that" (African American family member, pre-ESRD)." We did not detect substantial differences in participants' reported information needs according to their race or ethnicity (Table 3).

In this regard, the factors underlying the spread of CCHF in Bulgaria we found, although they have not yet fully clarified, can make a substantial contribution towards fulfilling the information needs of public health policy-makers when challenging CCHF in varying eco-epidemiological dimensions.

Our findings show that, at the time of market entry of a new drug, a substantial amount of information needed for assessment of the corresponding clinical studies and for understanding of the drug's benefits and harms is missing in publicly available European public assessment reports, journal publications, and registry reports (non-AMNOG documents).

We repeat them now because the MPP's Monitor casts a bright light on the criticality of this need and substantial information for rekindling the debate - and moving forward toward inclusive solutions for IEW.